Causes of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South Africa

Patients initiated on drug-resistant TB(DR-TB) treatment in 2019 in Khayelitsha, South Africa, with a loss to follow-up outcome were evaluated to better understand reasons for loss to follow-up and to determine if any had returned to care. Of a total of 187 patients, 28 (15%) were lost to follow-up...

Full description

Saved in:

Bibliographic Details
Published in:	Public health action Vol. 12; no. 2; pp. 55 - 57
Main Authors:	Memani, B., Beko, B., Dumile, N., Mohr-Holland, E., Daniels, J., Sibanda, B., Damse, Z., Scott, V., von der Heyden, E., Pfaff, C., Reuter, A., Furin, J.
Format:	Journal Article
Language:	English
Published:	International Union Against Tuberculosis and Lung Disease 21-06-2022 The Union
Subjects:	Lost From Care Notes from the Field rifampicin-resistant tuberculosis Socio-Economic Support Substance Use
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Patients initiated on drug-resistant TB(DR-TB) treatment in 2019 in Khayelitsha, South Africa, with a loss to follow-up outcome were evaluated to better understand reasons for loss to follow-up and to determine if any had returned to care. Of a total of 187 patients, 28 (15%) were lost to follow-up (LTFU), 24 (86%) of whom were traced: 20/24 (83%) were found when they re-presented to facilities and 8/28 (29%) were linked back to DR-TB care. People with DR-TB continue to seek care even after being LTFU; thus better coordination between different components of the healthcare system are required to re-engage with these patients. Interventions to mitigate the socio-economic challenges of people on DR-TB treatment are needed. Many people who were LTFU and symptomatic were willing to re-engage with DR-TB care, which highlights the importance of for compassionate interventions to welcome them back.
Bibliography:	2220-8372(20220621)12:2L.55;1- ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2220-8372 2220-8372
DOI:	10.5588/pha.21.0083